{"id":999795,"date":"2026-09-02T09:03:50","date_gmt":"2026-09-02T13:03:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/"},"modified":"2026-09-02T09:03:50","modified_gmt":"2026-09-02T13:03:50","slug":"alx-oncology-to-present-at-upcoming-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/","title":{"rendered":"ALX Oncology to Present at Upcoming Investor Conferences in September"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., Sept.  02, 2026  (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc. (&#8220;ALX Oncology&#8221;; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in fireside chats at three upcoming investor conferences.<\/p>\n<p>The details of the meetings are as follows:<\/p>\n<p>\n        <strong>Wells Fargo 21<\/strong><br \/>\n        <sup><br \/>\n          <strong>st<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Conference<\/strong>\n      <\/p>\n<p>Format: Fireside Chat and One-on-one Meetings<br \/>Date: Wednesday, September 9, 2026<br \/>Location: Boston, MA<br \/>Time of Fireside Chat Presentation: 3:45 PM ET<br \/>Webcast link: Available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0LzdvRMW0NQIa-zk69UbDSrpIAd_X7GnBL7Lh_G1LqNEcCp0tpQfRTY9y20ooBRDkySYhqMVWE_BhLCuvlsNRpFBoQ0M_L_lmMmVzsR4Hm5G8f0fYhm3anjYDSSaepSWvtphMo71HzEssxDD3ekUsQ==\" rel=\"nofollow\" target=\"_blank\"><u>here<\/u><\/a><\/p>\n<p>\n        <strong>Cantor Global Healthcare Conference<\/strong>\n      <\/p>\n<p>Format: Fireside Chat and One-on-one Meetings<br \/>Date: Thursday, September 10, 2026<br \/>Location: New York, NY<br \/>Time of Fireside Chat Presentation: 10:20 AM ET<br \/>Webcast link: Available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0LzdvRMW0NQIa-zk69UbDRm5NdbNvlRbSuqCVdtHtp4xPR_2FGnI3FyDnTPP6-pCshjL4DB89yB3SJOMN-YuXdAh_M7nUIcnMgXQOHxBJUiqj9ED-sApehOBJmWKjAy25SYJQwSOM6RQ02upUzULN9XmEqSeLIaOeqpbxrQLFiUc1iLjm7ljS81jnQtJHKKKmQQAp9BErJeuMn_EptElUFMixRFwmCwa7cU64tgH_9w=\" rel=\"nofollow\" target=\"_blank\">here<\/a><\/p>\n<p>\n        <strong>H.C. Wainwright 28<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Investment Conference<\/strong>\n      <\/p>\n<p>Format: Fireside Chat and One-on-one Meetings<br \/>Date: Monday, September 14, 2026<br \/>Location: New York, NY<br \/>Time of Fireside Chat Presentation: 1:30 PM ET<br \/>Webcast link: Available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0LzdvRMW0NQIa-zk69UbDXh7Z0-EKThZyZOA8DBK4da3yQXY4oeZYMDeHazaa8LtRcy0TeQmEPpUf0q5eeMpfwidZTUmdx4feSy0RV262QdHEQ2inZZFudKmnAXa77CJpDXsakX9cUWrWajCH73oYw==\" rel=\"nofollow\" target=\"_blank\"><u>here<\/u><\/a><\/p>\n<p>The webcasts of the fireside chats can be accessed through the links above or by visiting the Investors section of ALX Oncology\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=589sYkXjQjytQTtJqP8bFU6EonZBEUcQt3zj3vYMfa6JLZY_LOo0c8uWM42AMy0-zvn_EyrKk5tL0y0rrcRRX39ZjOIgx9tBvauiVJARR74=\" rel=\"nofollow\" target=\"_blank\"><u>www.alxoncology.com<\/u><\/a> under the Events section of the Events and Presentations tab. Replays of the webcasts will be archived for up to 90 days following the presentation dates.<\/p>\n<p>\n        <strong>About ALX Oncology<\/strong><br \/>\n        <br \/>ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives. ALX Oncology\u2019s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. ALX Oncology\u2019s second pipeline candidate, ALX2004, is a novel EGFR-targeted antibody-drug conjugate with a differentiated mechanism of action. A Phase 1, dose-escalation trial of ALX2004 is ongoing in patients with EGFR-expressing solid tumors. More information is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=589sYkXjQjytQTtJqP8bFftJrbHrpw-uzwHqX8z4y1OIU1LAV2ZsrX7fpsAGdXUblS1pKlf2oxgy6_u-0BxA6lKqJoPeDCdO2PEmR1WYv9c=\" rel=\"nofollow\" target=\"_blank\"><u>www.alxoncology.com<\/u><\/a> and on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=35Sjbu6yvderUJU438hSL0bKOkdbOisc3fNvtAHEJhmxYxwW76m0QyQ1cJ-ZS8IeKFE0Hkpw9bd-kTr5uzZSIARsdywo289qWdYF2-gLDeHxbY5MbPsWT_3ZLkPtqSsWZ26lS7euZjgE9QL7KbL8FA==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Kevin Lui<br \/>Director, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=trMmp9CCBdFVsuXLk5FlPeK_AOo581DrYNzo1zkkPLJnlvPq0z8f_yAoH_lGefIDxAPDDi830G61Ac3paS8HPGYfVCspl_j5suz4PzRJCVekHcLcgh7gWBQAZgK6hq6Z\" rel=\"nofollow\" target=\"_blank\"><u>kevin.lui@precisionaq.com<\/u><\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Genevieve Britton<br \/>Senior Director, Public Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F1_zlDaofNFp6tLhAhQi87bV27QFIqp9uL7EQK2vwpa0PqW68lCaWqreTbZsZqZt1ibl-p_8rTWLXQgFv4RJqqRefHxoIaq2PURDqwOij4dGlPv3y7Y3iuMoDParLRt7pkL3y75EucWDq15dn7hcmA==\" rel=\"nofollow\" target=\"_blank\"><u>genevieve.britton@precisionaq.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGZkOTk0NGQtOWNlMi00NmZmLWJmYzItODI5NDk0NzhlNGYzLTEyMDQ0MTYtMjAyNi0wOS0wMi1lbg==\/tiny\/ALX-Oncology.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc. (&#8220;ALX Oncology&#8221;; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in fireside chats at three upcoming investor conferences. The details of the meetings are as follows: Wells Fargo 21 st Annual Healthcare Conference Format: Fireside Chat and One-on-one MeetingsDate: Wednesday, September 9, 2026Location: Boston, MATime of Fireside Chat Presentation: 3:45 PM ETWebcast link: Available here Cantor Global Healthcare Conference Format: Fireside Chat and One-on-one MeetingsDate: Thursday, September 10, 2026Location: New York, NYTime of Fireside Chat Presentation: 10:20 AM ETWebcast link: Available here H.C. Wainwright 28 th &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ALX Oncology to Present at Upcoming Investor Conferences in September&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-999795","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ALX Oncology to Present at Upcoming Investor Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALX Oncology to Present at Upcoming Investor Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc. (&#8220;ALX Oncology&#8221;; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in fireside chats at three upcoming investor conferences. The details of the meetings are as follows: Wells Fargo 21 st Annual Healthcare Conference Format: Fireside Chat and One-on-one MeetingsDate: Wednesday, September 9, 2026Location: Boston, MATime of Fireside Chat Presentation: 3:45 PM ETWebcast link: Available here Cantor Global Healthcare Conference Format: Fireside Chat and One-on-one MeetingsDate: Thursday, September 10, 2026Location: New York, NYTime of Fireside Chat Presentation: 10:20 AM ETWebcast link: Available here H.C. Wainwright 28 th &hellip; Continue reading &quot;ALX Oncology to Present at Upcoming Investor Conferences in September&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T13:03:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ALX Oncology to Present at Upcoming Investor Conferences in September\",\"datePublished\":\"2026-09-02T13:03:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/\"},\"wordCount\":335,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/\",\"name\":\"ALX Oncology to Present at Upcoming Investor Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM=\",\"datePublished\":\"2026-09-02T13:03:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALX Oncology to Present at Upcoming Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALX Oncology to Present at Upcoming Investor Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"ALX Oncology to Present at Upcoming Investor Conferences in September - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc. (&#8220;ALX Oncology&#8221;; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in fireside chats at three upcoming investor conferences. The details of the meetings are as follows: Wells Fargo 21 st Annual Healthcare Conference Format: Fireside Chat and One-on-one MeetingsDate: Wednesday, September 9, 2026Location: Boston, MATime of Fireside Chat Presentation: 3:45 PM ETWebcast link: Available here Cantor Global Healthcare Conference Format: Fireside Chat and One-on-one MeetingsDate: Thursday, September 10, 2026Location: New York, NYTime of Fireside Chat Presentation: 10:20 AM ETWebcast link: Available here H.C. Wainwright 28 th &hellip; Continue reading \"ALX Oncology to Present at Upcoming Investor Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-02T13:03:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ALX Oncology to Present at Upcoming Investor Conferences in September","datePublished":"2026-09-02T13:03:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/"},"wordCount":335,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/","name":"ALX Oncology to Present at Upcoming Investor Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM=","datePublished":"2026-09-02T13:03:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODkwNSM3ODEwODA1IzIxOTI4NjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ALX Oncology to Present at Upcoming Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=999795"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999795\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=999795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=999795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=999795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}